A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

NCT01527305 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone palmitate

Sponsor

Janssen Research & Development, LLC